POTENTIAL VALUE OF REPERTOIRE SEQUENCING IN DRUG DISCOVERY AND DEVELOPMENT
Overall, 70.6% of respondents to a certain extent believe that insights from Rep-seq could potentially be valuable for their own business operations. Of the total number of respondents, 17.6% strongly agreed, 35.3% agreed, and 17.6% more or less agreed that these insights could potentially be valuable for their own business operations.
Possible applications of Rep-seq analysis that respondents could think of for their own organizations were “analysis of infiltrating T cells before, during and after treatment”, “screen treated patients before and after therapy”, “identify patients that have established tumor specific immune responses”, and “clone selection”.
Many more detailed findings, a list of references, a discussion of the results and conclusion by the author are now available in a 10-pages report.